India's Opto Circuits expands with Criticare
This article was originally published in Clinica
Bangalore-based Opto Circuits, said to be one of India's leading healthcare equipment manufacturers, is to grow its patient monitoring business with the acquisition of US firm Criticare Systems. Opto definitively agreed on Monday (Feb 25) to buy Milwaukee, Wisconsin-based Criticare for $5.50 per share, giving the total transaction a value of $68m. The purchase price represents a 19% premium over Criticare's closing price on Feb 22.
You may also be interested in...
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.
In addition to our daily in-depth coverage of key regulatory events relating to the coronavirus pandemic, we’re bringing you selected brief insights into the impact on biopharma commercial activities.